Clin2
NCT06969937Likely a fitRecruiting

Ketamine and Neurofeedback for Alcohol Use Disorder

Alcohol Abuse/DependenceAlcohol Use Disorder (AUD)Alcoholism

Treatments studied

Part of Mental health clinical trials.

This study tests whether combining ketamine with a brain-training technique called neurofeedback can help people reduce or stop drinking alcohol. It may offer a new treatment option for alcohol use disorder.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
75 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 to 65 years old.
  • You have a diagnosis of alcohol use disorder (mild to severe) and want to cut down or stop drinking.
  • You are generally healthy with no unstable medical conditions.
  • You are not pregnant, breastfeeding, or planning to become pregnant, and you use effective birth control if needed.
  • You have not used ketamine or hallucinogens in the past 3 months, and you are not dependent on other drugs (except nicotine or caffeine).
  • You have no history of psychotic disorders, bipolar disorder, or recent suicide attempts.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07247370Not yet recruiting· Phase 1/Phase 2
Ketamine therapy for alcohol use and depression

This study tests if ketamine-assisted therapy can help people who struggle with both alcohol use disorder and depression. You'll receive ketamine alongside psychological support to see if it reduces drinking and improves mood.

Sydney, New South Wales
NCT07746154Not yet recruiting
Brain wave training for alcohol use disorder

This study tests a type of brain training called neurofeedback that aims to help people with alcohol use disorder by changing the activity of their brain waves. It will check if this training is practical and acceptable for people who drink alcohol regularly.

NCT02122562Recruiting· Phase 2
Ketamine treatment for depression that hasn’t responded to care

This Phase 2 study tests ketamine for people with major depression that hasn’t improved after at least one antidepressant. It aims to see whether ketamine can reduce depression symptoms during a current depressive episode.

Iowa City, Iowa
NCT06125054Recruiting· Phase 2
Ketamine and brain training for cocaine addiction

This trial tests whether a combination of ketamine (a medicine that may help the brain change) and neurofeedback training (a brain-exercise technique) can help people with cocaine addiction. The goal is to see if these treatments can improve brain flexibility and reduce cravings.

Zurich, Canton of Zurich
NCT06247306Recruiting
Neurofeedback and stress in alcohol use

This study uses a brain-training technique called neurofeedback to help understand how stress and drinking are linked. You would use your smartphone to participate, and the goal is to find better ways to manage alcohol use.

Mannheim, Baden-Wurttemberg
NCT06620276Recruiting
Ketamine and therapy for alcohol use disorder and depression

This trial tests if combining ketamine infusions with weekly therapy can help people who have both alcohol use disorder and hard-to-treat depression. You may qualify if you drink at least moderately, have treatment-resistant depression, and are willing to attend 8 therapy sessions.

Montreal, Quebec

Hear when a new Alcohol Abuse/Dependence trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.